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Evaluation of sensitivity to chemotherapeutants in successive generations of 
Lepeoptheirus salmonis from a resistant population.
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1. INTRODUCTION 
 
1.1 Study Background 
There are currently reports of reduced sensitivity to certain lice treatments in different 
parts of Scotland and world-wide, and research is on-going into the extent and 
mechanisms of resistance to different treatments (Denholm et al., 2002; Sevatdal & 
Horsberg, 2003; Sevatdal et al., 2005). In particular, increasing evidence of resistance of 
Lepeophtheirus salmonis to the chemotherapeutant emamectin benzoate (Lees et al., 
2008; Espedal et al., 2010) poses a serious problem to commercial farms because there 
are few licensed and effective treatments available. 
 
In order to address the heritability of this trait we assessed the sensitivity of successive 
generations of emamectin-resistant (RS) and emamectin-sensitive (naïve, NV) L. 
salmonis. Machrihanish Experimental Research Laboratory (MERL) was in a unique 
position to be able to conduct this study as we had maintained two verified strains of L. 
salmonis on site in isolation and in the absence of treatment. The naïve strain was 
originally taken from a farm site where the only treatment that had been used was 
hydrogen peroxide. Lice from this site were collected in approximately 2001 and had 
been cultured since without exposure to any lice treatment. The resistant strain was 
established in 2008 for the purposes of a separate experimental study. These lice had 
been shown to be five to seven times less sensitive to emamectin benzoate than the naïve 
strain using bioassays and in vivo treatments (unpublished data). The strain had also been 
shown to have reduced sensitivity to other licensed treatments (unpublished data).  
 
Through producing multiple generations of both lice strains in the absence of treatments 
and through the hybridisation of the lice strains under controlled conditions, this study 
aimed to investigate if resistance to lice treatments could be reduced at the population 
level and thus make the lice treatments effective again at farms where resistance occurs. 
 
The study ran from February 2010 up to February 2011. 
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1.2 Objectives 
The main objectives of the study as set out in the original application were as follows: 
1) To maintain populations of naïve and resistant lice in culture through multiple 
generations. 
2) To monitor sensitivity levels to a given treatment over a period of 12 months and 
up to 6 subsequent generations in a population of resistant lice in the absence of 
any treatments. 
3) To measure the fecundity and successful hatching and development of lice from 
each generation compared to a naïve control population of lice. 
4) To determine the sensitivity to a given treatment of hybrids of resistant and naïve 
lice strains. 
 
2. MATERIALS AND METHODS 
 
2.1 Objective 1. Maintenance of naïve and resistant lice strains through multiple 
generations 
Prior to the start of this study, the naïve lice strain (NV) had been cultured in laboratory 
conditions through at least 40 generations since being collected from a farm site. The 
resistant strain (RS) had been cultured through approximately eight generations since it 
was first established. As the results of this study appertain to the sensitivity of each 
subsequent generation of resistant lice since the last emamectin treatment, the results of 
bioassays conducted prior to the start of this study are also included in the results that 
follow. 
 
2.1.1 Culturing of Lice  
Both strains of lice were maintained onsite under a Home Office project licence, by 
infecting fish, allowing lice to develop to adults and produce eggs which were then 
collected and used to re-infect fish. 
 
For the collection of lice eggs, ovigerous female lice were removed from host fish and 
incubated at ambient tank temperatures in 10L culture vessels. Eggs were left to hatch 
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and develop to the infective copepodid stage. Aeration and daily partial water changes 
were performed to maintain the cultures. When copepodids were present, aliquots of 
culture water from each vessel were examined under a dissecting microscope to estimate 
the total number of copepodids present. 
 
Experimental fish were then challenged with lice copepodids in tank water. Challenges 
were conducted at the ambient temperature of the inflowing water except when this fell 
below 10ºC and water was heated to maintain this level from the day prior to until the day 
following challenge. During the challenge, water inlets were switched off and levels 
reduced. Aeration and mixing was provided with air stones and oxygen levels monitored. 
When necessary, oxygen was diffused into tank water to keep levels above 6mg/L.  The 
number of copepodids used was selected to provide an expected settlement rate of at least 
20 lice per fish. Following challenge, a minimum of two fish were selected from each 
tank and examined under anaesthesia with 2-phenoxyethanol to determine the level of 
lice settlement. The fish were returned to the tanks.  Where lice settlement was below the 
level required, a repeat challenge using lice from the same cohort of copepodids was 
conducted as soon as possible where louse numbers allowed.  
 
2.1.2  Fish Stock  
Mixed sex Atlantic salmon (Salmo salar L.), with an initial mean weight of 200-500g, 
were used for the sea lice culture. The numbers of fish used for infection of each 
generation of lice ranged from 20 to 50 depending on the numbers of lice copepodids 
available to infect the fish. 
 
2.1.3 Fish Holding Conditions 
Fish were held in circular glass reinforced plastic (GRP) tanks (1m and 3m diameter). 
Tanks were provided with a continuous supply of seawater. Light was supplied to each 
tank on a photoperiod that corresponded with the natural conditions of sunrise and sunset 
and was adjusted each week. Water recirculation was not used. All tanks were cleaned, 
disinfected and rinsed before stocking with fish.   
 
5 
 
2.2 Objective 2. Stability of sensitivity to Emamectin benzoate in multiple 
generations of naïve and resistant lice  
Bioassays were used to test the sensitivity of the NV and RS strains of lice to emamectin 
benzoate (EB). The estimated EC50 values from the bioassays were compared for the two 
strains. EC50 was defined as the effective concentration at which 50% of lice in a 
population were affected. 
 
2.2.1 Test Material 
The test material for the bioassays was technical grade emamectin benzoate (EB). Test 
material was supplied by Intervet/Schering-Plough and stored dry and in the dark 
according to label conditions.  
 
2.2.2 Bioassay Methods 
Fish were netted and killed by cervical dislocation. Lice were removed using fine 
forceps. Adult male lice were transferred to plastic bags containing 8-10 litres of clean 
seawater from the collection site at ambient salinity and temperature. When enough lice 
were collected, the remaining fish were left until the female lice had become gravid.  
These were later collected the same way and transferred to the MERL culturing system to 
incubate eggs for infecting fish with the next generation. It was decided to only conduct 
assays on adult male lice as removing female lice for this purpose may have endangered 
the continuity of the cultures by having insufficient eggs for the subsequent generation.  
The adults males used in each bioassay were of a similar age, all being tested 1-2 weeks 
after moulting to the adult stage.   
 
Bags containing lice for bioassays were transferred to an incubator set at 12ºC until 
temperatures had equilibrated.  Live lice were added to deep-sided 100 mL plastic Petri 
dishes containing 70mL of test solution (see 2.2.3) as soon as possible after water 
temperatures had reached 12ºC. 
 
Lice were held in test solutions in a dark incubator for 24 hours at 12ºC.  No additional 
water or aeration was supplied. 
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There were eight test doses for each louse strain within each generation. Doses were 
tested in duplicate. Doses were as follows:  
1) Placebo control containing Polyethylene glycol (PEG) 300 
2) EB in PEG 300 diluted in sea water.  EB concentration 2000ppb 
3) EB in PEG 300 diluted in sea water.  EB concentration 1000ppb 
4) EB in PEG 300 diluted in sea water.  EB concentration 500ppb 
5) EB in PEG 300 diluted in sea water.  EB concentration 250ppb 
6) EB in PEG 300 diluted in sea water.  EB concentration 125ppb 
7) EB in PEG 300 diluted in sea water.  EB concentration 62.5ppb 
8) EB in PEG 300 diluted in sea water.  EB concentration 31.25ppb 
 
In later assays of the hybrid strains, both adult male and adult female lice were tested. 
2.2.3 Preparation of Test Solutions  
Test doses were prepared not more than 2 hours before the start of each assay.  Technical 
grade emamectin benzoate (EB) was dissolved in PEG300 at 5 mg/mL. 1 mL was further 
diluted in 999 mL of filtered seawater to make 5 mg/L. 250 mL of each test dose was 
made up by taking different amounts of the 5 mg/L stock and making up to 250 mL with 
seawater and also PEG300 (Table 1). The PEG300 was added to each dose so that each 
contained 0.1 mL, this was equivalent to the volume of PEG300 used to make up the 
highest test dose.  
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Table 1: Preparation of emamectin benzoate (EB) test solutions. Volume of 5 mg/L EB 
solution, seawater and PEG300 required to make 250 mL of a test solution at different 
doses 
EB Test 
Dose (ppb) 
Vol. of 5 mg/L stock 
added (mL) 
Vol. seawater 
added (mL) 
Vol. of PEG300 
added (mL) 
2000 100.000 150.000 - 
1000 50.000 199.950 0.050 
500 25.000 224.925 0.075 
250 12.500 237.413 0.088 
125 6.250 243.656 0.094 
62.50 3.125 246.778 0.097 
31.25 1.563 248.339 0.098 
0 0 249.900 0.100 
 
Sea lice were randomly allocated to the experimental Petri dishes so that each contained 5 
male lice. 
 
Petri dishes were removed from the incubator after 24 hours of the exposure period.  Lice 
were examined and recorded as live, dead or moribund. The number of affected lice were 
those recorded as dead or moribund vs. those live (still able to swim normally and re-
attach when detached from the vessel surface). Examinations were not performed on a 
blinded basis. This could be considered in future studies.  
 
2.2.4 Data Analysis 
Probit analysis was used to generate EC50 data for male lice within each strain for each 
bioassay. The software used for this was Minitab v.13 (Minitab Inc). 
 
2.3 Objective 3. Fecundity and egg hatching 
Following a review of literature it became evident that data on egg string length and 
hatchability could not be expected to demonstrate differences in fitness between naïve 
and resistant sea lice. More complex studies are necessary to identify the ‘fitness cost’ of 
emamectin resistance in sea lice.  
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2.4 Objective 4. Determination of sensitivity to EB of F1 hybrids between naïve and 
resistant lice strains 
2.4.1 Generation of hybrid strains 
Gravid female lice were collected from the resistant strain (generation 12) and naïve 
strain of lice and eggs were hatched and developed to copepodid stage. Two tanks, each 
containing 70 salmon were infected using the methods previously described. When adult 
males and pre-adult females had developed, fish were killed by cervical dislocation and 
lice removed with forceps to petri dishes. Under a dissecting microscope, lice were sorted 
into male and female stages using the shape of the genital segments as the criterion. 
Where it was uncertain of the sex of the louse, it was discarded.    
 
A further two tanks of 20 fish each were set up and infected with the collected lice as 
follows: 
1) To the first tank were added adult male lice from the RS strain and pre-adult 
female (virgin) lice from the NV strain. 
2) To the second tank of fish were added adult male lice from the NV strain and pre-
adult female (virgin) lice from the RS strain. 
 
The water flows were switched off for 3 hours until most of the lice added to the tanks 
had attached to the fish. 
  
The fish were maintained until lice had mated and females had produced egg strings. The 
eggs were collected and incubated and used to infect a further two tanks with the methods 
previously described. These lice were F1 hybrids, described thereafter as F1a (RS male  + 
NV female parents ) and F1b (RS female + NV male parents).   
 
When the F1 hybrids had developed to adult stages (pre-gravid), lice were removed and 
bioassays performed. The remaining lice were left until eggs were being produced, then 
they were collected, pooled as a single F1 strain, incubated and used to infect fish in the 
in vivo study described below (section 2.4.3). The pooled F1 strain is referred to as the 
HB strain (hybrid strain) in later sections of the report. 
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2.4.2  Bioassay for two strains of F1 hybrid lice (pre in vivo trial) 
Two bioassays were set-up on the 7th July 2010, one for the F1a hybrid strain and one for 
the F1b hybrid strain. The bioassay procedure was in accordance with the set-up 
described in section 2.2. Five adult males and five adult females (pre-gravid) were 
allocated to each dose.  
 
2.4.3  In vivo testing of hybrid Lice  
For the experimental lice challenge, three 2m diameter tanks each containing 70-160 
Atlantic salmon (100-150g) previously marked with a passive transponder chip (PIT tag) 
were set-up. Each tank of salmon were each challenged with either NV, HB or RS lice. 
Lice were allowed to develop to chalimus III/IV stages. The pre-treatment  sample, Time-
point 1, was conducted on the 11-12th December 2010 (Days -7, -8). Fish were 
anaesthetised with 2-phenoxyethanol, weighed, examined for lice, PIT tag recorded and 
allocated to 1m diameter tanks so that there were 6 tanks in total, each containing 25 fish, 
with 2 tanks for each strain of lice. 
 
Fish were then allowed time to recover from the handling and resume normal feeding 
behaviour. Lice continued to develop during this period to motile stages.  Fish were then 
starved for one day on the 19th January 2011 (Day 0) and experimental feeds were 
supplied to the fish for seven days (Day 1 to 7). The test material was Slice® premix 
(Intervet/Schering-Plough Animal Health), containing 0.2% emamectin benzoate, 
prepared as medicated feed. This was stored dry and in the dark according to label 
conditions. The groups and diets presented are shown in Table 2. 
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Table 2: Summary of experimental groups including experimental group name, lice 
strain and treatment. 
 
 
Sampling Time-point 2 was on the 27th January 2011 (Day 8, 1 day post-treatment) when 
5 fish per tank were killed by cervical dislocation, weighed, examined for lice and pit tag 
removed and recorded.   
 
Sampling Time-point 3 was on the 16th February 2011 (Day 28, 21 days post-treatment), 
three weeks after the last day of experimental feeding. The remaining fish in each tank 
were killed and sampled as described above.  Lice were removed from fish at this stage 
and used for further bioassays. 
 
During the experimental feeding phase, three meals per day were presented to the fish 
and uneaten pellets were collected in fine screens in each tank outflow. The number of 
pellets collected was converted to a dry weight of uneaten feed in order to estimate the 
mean dosage administered for each tank.  
 
The basal feed used throughout the study was Biomar Pearl 3 mm.  The mean weight of 
fish estimated on Day 0, based on the weights recorded at allocation plus an estimated 
gain in the interim was 142g. Experimental diets were prepared by weighing out the 
appropriate amount of feed into a polythene bag, adding the necessary amount of Slice, 
turning the pellets for 5 minutes until the powder appeared homogenous and then top 
coating with 1% v/v of pure cod liver oil (Seven Seas Healthcare, Marfleet, UK) and 
turning for a further 5 minutes. No premix was visibly left in the bag, all appeared to be 
adhered to the pellets. Control diets were prepared in the same way using a clean new 
polythene bag with only the addition of the fish oil. 
Group Lice strain Diet for 7 days 
NV Control Naïve Control 
NV Treated Naïve Slice to deliver 50µg EB/kg/day 
HB Control F1 Hybrid Control 
HB Treated F1 Hybrid Slice to deliver 50µg EB/kg/day 
RS Control Resistant Control 
RS Treated Resistant Slice to deliver 50µg EB/kg/day 
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2.4.4  Bioassay for NV, HB and RS strains of lice (post in vivo trial) 
Lice removed at Time-point 3 were further tested in bioassays using the procedure 
previously described. Lice from the NV control, HB control and RS control tanks were 
each tested in a bioassay. Around 3-5 adult males and 3-5 adult females (pre-gravid) were 
allocated to each dose. There were not always 5 individuals of each sex available, after 
the in vivo trial, to be added to each dose. 
 
2.4.5 Data Analysis  
Regarding the bioassays, Probit analysis was used to generate EC50 data for male and 
female lice separately within each strain for each bioassay.  
 
For the in vivo trial, sea lice count data were summarised for each tank. Mean number, 
standard deviation and median number of lice per fish were calculated for tanks. Due to 
low sample sizes and sea lice infections typically being over dispersed, non-parametric 
statistics were used to compare lice counts between tanks based on sample median lice 
infections. Significant differences in median lice count between all tanks at Time-point 1 
were compared using a Kruskal-Wallis test. For Time-points 2 and 3, significant 
differences in median lice count between the treatment tank and control tank for each lice 
strain were compared using Mann-Whitney tests.  
 
To determine the efficacy of EB treatment for each strain in the in vivo trial, a modified 
Henderson-Tilton formula was applied as follows: 
 
Corrected % = (1-(mean of control before treatment*mean of treated after 
treatment)/(mean of control after treatment*mean of treated before treatment))*100 
 
The Henderson-Tilton formula was applied to data for both Time-point 2 and 3.  
 
All statistical analysis was conducted using either Minitab version 13 or GraphPad InStat 
software. In all cases a significance level of p<0.05 was set. 
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3. RESULTS 
 
3.1. Maintenance of naïve and resistant lice strains through multiple generations 
The lice from the NV and RS strains were successfully cultured through 16 generations in 
laboratory conditions with no apparent loss of viability or changes in morphology or 
behaviour.  
 
3.2. Stability of sensitivity to EB in multiple generations of naïve and resistant lice 
Table 3 shows the results of the bioassays of naïve and resistant strains of lice before and 
during this study. Results are included from prior to the study (generations 0-7 inclusive) 
in order to show stability since the resistant strain were first cultured in the laboratory. 
The data is graphically illustrated in Figure 1. 
 
Table 3: EC50 values for successive generations of pure NV and RS strains of L. salmonis 
cultured separately in the absence of lice treatments. Lice were exposed to emamectin 
benzoate at 12 ºC for 24 hours in dark conditions. Data are presented for adult male lice 
only. All values are parts per billion (ppb), with 95% confidence intervals reported. Lw 
95% = lower 95% confidence interval, Up 95% = upper 95% confidence interval. 
Adult male RS lice Adult male NV lice 
  
Date 
  
Generation EC50 
Lw 
95% 
Up 
95% EC50 
Lw 
95% 
Up 
95% 
11/12/2008 Gen 0 715 550 1048 141 104 190 
10/03/2009 Gen 1 1211 766 2442 145 106 207 
10/07/2009 Gen 3 732 601 989 145 106 207 
25/10/2009 Gen 7 823 744 960 121 94 192 
02/03/2010 Gen 9 814 700 990 131 87 299 
06/04/2010 Gen 10 853 683 999 101 72 171 
17/06/2010 Gen 12 732 622 921 114 85 170 
24/11/2010 Gen 15 620 535 796 189 121 398 
16/12/2010 Gen 16 940 754 1220 122 91 189 
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Figure 1: EC50 values of emamectin benzoate for NV and RS strains of lice. Lice were 
cultured in laboratory conditions in the absence of any louse treatments. Error bars denote 
95% confidence intervals. 
 
In all assays, the adult male lice from the resistant RS strain were less sensitive to EB 
than those from the naïve strain. The level of sensitivity in both strains was fairly 
consistent over the 16 generations with approximately six-fold less sensitivity in the RS 
strain. There was an anomalous result for the RS strain in Generation 1 where confidence 
intervals were very high. This may be explained as there were fewer adult males 
available for testing in this assay (n=10 per dose) compared to other assays (n≥20 per 
dose). 
 
3.3 Fecundity and egg hatching 
Relative fecundity and egg hatchability were not evaluated for the reasons described in 
section 2.3 and discussed in section 4.  
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3.4 Determination of sensitivity to EB of F1 hybrids between resistant and naïve lice 
strains 
3.4.1 Bioassay results for two strains of hybrid lice (F1a and F1b) 
Bioassay results for the two strains of hybrid lice (F1a and F1b) are presented in Table 4 
and graphically presented in Figure 2. EC50 values were between those seen for NV and 
RS lice. In particular, the EC50 of F1 hybrid males were 348 and 435. These lay between 
the NV EC50 (114) and RS EC50 (732) of males in generation 12 (parents of the hybrids). 
The EC50 value did not differ greatly according to the sex of the resistant parent. The two 
types of F1 hybrid produced were therefore mixed for further use in tank trials. 
 
Table 4. EC50 values for adult male and adult female (pre-gravid) lice exposed to 
emamectin benzoate at 12 ºC for 24 hours in dark conditions. All values are ppb, with 
95% confidence intervals reported. Lw 95% = lower 95% confidence interval, Up 95% = 
upper 95% confidence interval.  
Hybrid 
strain 
Parents Test Subject EC50 Lw 95% Up 95% 
Adult male  435 335 573 F1a NV female + 
RS male Adult female  250 196 318 
Adult male  348 231 525 F1b NV male + 
RS female Adult female  174 144 300 
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Figure 2: EC50 values for EB for two hybrid strains of lice: F1a and F1b. Strains have 
different parentage. Results are presented for male and female lice separately. Error bars 
denote 95% confidence intervals. 
 
3.4.2 In vivo results for hybrid lice  
3.4.2.1 Time-point 1: Days -8 and -7 
The mean lice counts for the three strains of lice when examined at chalimus III stage 
prior to treatment are presented in Table 5. A non-parametric Kruskal-Wallis test showed 
that there were no significant differences in the number of lice per fish between tanks (p 
= 0.24, KW=6.70). 
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Table 5. Summary data of lice counts at Time-point 1 (pre- treatment). The table presents 
the mean, standard deviation (SD) and median number of lice per fish for each group (n= 
25 fish/group). The majority of lice were at the chalimus III stage. 
 
Group Mean no. lice per fish SD Median no. lice per fish 
NV Control 25.8 21.4 22 
NV Treated 22.6 12.9 19 
HB Control 26.6 10.7 25 
HB Treated 26.8 11.8 26 
RS Control 23.8 7.3 22 
RS Treated 21.9 7.3 21 
 
3.4.2.2 In-feed Dose 
Slightly above target dosing was achieved for all treatment groups. Mean dose delivery 
for each treatment group was as follows: 
NV treated group – 53.1 µg/kg/day 
HB treated group – 53.2 µg/kg/day 
RS treated group – 52.7 µg/kg/day 
 
3.4.2.3 Time-point 2: Day 8 (27/01/11) 
The summary data for lice counts for the three strains of lice when examined on Day 8 
are presented in Table 6. At this time, Slice was shown to be 80% effective against the 
naïve strain of lice, ineffective (0%) against the hybrid strain and only 11.5% effective 
against the RS strain. A Mann-Whitney U test revealed significantly fewer lice per fish in 
treated than control groups of the NV strain (U =25 , p =<0.01 ). Tests did not reveal a 
significant difference between the control and treated groups for the hybrid strain (U =18, 
p =0.31) or the RS strain (U =14.5, p =0.75). 
 
17 
 
Table 6. Summary data of lice counts at Time-point 2 (immediately following treatment). 
The table presents the mean, standard deviation (SD) and median number of lice per fish 
for each group (n=5 fish/group). The majority of female lice were at the pre-adult II 
stage. The majority of male lice were at the adult stage. Efficacy of treatment is also 
given.  
Group Mean no. lice per fish SD Median Efficacy (%) 
NV Control 20.2 3.4 21.0  
NV Treated 4.0 1.9 4.0 80.0 
HB Control 19.0 2.4 19.0  
HB Treated 15.8 6.8 17.0 0 
RS Control 18.6 7.2 21.0  
RS Treated 17.8 8.2 21.0 11.5 
 
 
3.4.2.4 Time-point 3: Day 28 (16/02/11) 
The summary data for lice counts for the three strains of lice when examined on Day 28 
are presented in Table 7 and illustrated in Figure 3. Slice was shown to be 98% effective 
against the naïve strain of lice, 3.2% against the Hybrid strain and 0% against the RS 
strain. A Mann-Whitney U test revealed significantly fewer lice per fish in treated than 
control groups of the NV strain (U =330.5 , p =<0.01 ). Tests did not reveal a significant 
difference between the control and treated groups for the hybrid strain (U =201.5, p 
=0.11) or the RS strain (U =231, p =0.41). 
 
Table 7. Summary data of adult lice counts at Time-point 3 (Day 28). The table presents 
the number of fish sampled and the mean, standard deviation (SD) and median number of 
adult lice per fish for each group. All lice were adults. Efficacy of treatment is also given.  
Group Number of 
fish 
Mean no. 
lice per fish 
SD Median Efficacy 
(%) 
NV Control 18 5.3 4.4 4.0  
NV Treated 19 0.1 0.3 0.0 98 
HB Control 17 8.1 3.4 9.0  
HB Treated 18 10.4 3.6 10.0 3.2 
RS Control 20 7.7 3.3 7.0  
RS Treated 20 6.9 3.1 6.5 0 
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Figure 3: Mean number of lice per fish for the control and treated groups within the NV, 
HB and RS lice strains. Data is presented for Sample 3 (3 weeks post Slice treatment).  
Bars are divided into the mean number of adult males and adult females NG (non-gravid) 
and G (gravid) per fish (see Table 6 for the number of fish sampled). 
 
3.4.3 Bioassay results for hybrid lice following the in vivo trial  
Lice were removed from the three control tanks (NV control, Hybrid control, RS control) 
from the in vivo study and tested in a bioassay. The lice were tested for sensitivity to 
emamectin. The results from the bioassay are summarised in Table 8 and graphically 
presented in Figure 4. Estimated EC50 values for F1 Hybrids (HB) were between those 
seen for the pure NV and RS strain for both male and female lice. 
 
Table 8. Estimated EC50 values for adult male and adult female L. salmonis exposed to 
emamectin benzoate at 12 ºC for 24 hours in dark conditions. All values are ppb, with 
95% confidence intervals reported. Lw 95% = lower 95% confidence interval, Up 95% = 
upper 95% confidence interval. 
Adult males Adult females 
Group EC50 
Lw 
95% up 95% EC50 Lw 95% up 95% 
NV control 151.8 66.9 208.3 117.6 24.8 144.1 
HB control 739.2 570.5 957.5 314.0 213.9 404.2 
RS control 944.1 774.5 1150.4 445.1 370.5 543.6 
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Figure 4: EC50 values of EB for NV, HB and RS strains of lice. Results for male and 
female lice are presented separately. Lice were removed from fish from the control tanks 
from the in vivo study. Error bars denote 95% confidence intervals. 
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4. DISCUSSION 
 
This study has demonstrated that lice of the two strains, naïve (NV) and resistant (RS), 
can be successfully cultured through multiple generations in laboratory conditions.  
 
Sensitivity measured by EC50 to emamectin benzoate within the two strains did not 
change considerably during 16 generations in the absence of either selection by drugs or 
gene flow. This implies that there is a heritable genetic basis to sensitivity in the NV 
strain and to reduced sensitivity in the RS strain. The stability of the generations gives 
confidence in the value of these strains as reference standards for the determination of 
chemotherapeutant efficacy. 
 
F1 Hybrid lice between the NV and RS strains showed an estimated EC50 value between 
those of parent strains when tested using bioassays. This was found to be independent of 
the strain of the father or mother. This supports the idea that reduced sensitivity has a 
genetic basis and is heritable from either the mother or father in a semi-dominant fashion. 
 
In the tank study using Slice at the recommended dose (50 µg EB/kg/day), there was no 
clear sensitivity in either the RS strain or F1 hybrid strain whereas 98% of NV strain 
were affected. Thus  a potential threshold dose which might start to affect hybrid lice but 
not RS lice had not been reached. It is difficult to compare the dosage in the two 
approaches taken (bioassay versus tank). It seems likely that in the tank study, hybrid lice 
were being exposed to concentrations below the EC50 level identified by bioassay. Indeed 
the routes tested in the bioassays and tanks trials prevent comparisons - lice in the 
bioassays were topically exposed to EB for 24 hours whereas lice in the tank study were 
exposed to EB by feeding on the fish over a number of days. 
 
This study has focussed on sea lice resistance in experimental culture conditions and 
provided information as to the mechanism of resistance in sea lice. It has confirmed that 
reduced sensitivity to EB is a heritable trait in sea lice. It has also shown that in the 
absence of selection pressure (in favour of EB resistance) or gene flow, sensitivity within 
an isolated lice population was not restored in our study over 16 generations. Gene flow 
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through breeding with more sensitive lice appears to, however, reduce or dilute genetic in vitro 
resistance in the absence of selection pressure. This effect is likely to be present in any farm 
setting, albeit to unknown levels. This suggests that forgoing drugs to which genetic or cross-
resistance resistance has appeared and allowing seeding of the population with more sensitive 
lice, could over time lead to a restoration of sensitivity.  
 
Further work is necessary to address whether genetic variants conferring resistance incur 
a ‘fitness cost’ to the lice. In drug-resistant Drosophila melanogaster, Kane et al. (2000) 
identified reduced brood size and a reduction in locomotion and bang sensitivity. Espedal 
et al. (2010) investigated the fitness cost of emamectin resistance in L. salmonis in terms 
of fecundity and developmental success. They compared the length of egg strings, the 
hatching success and the survival of copepodids for a naïve strain of lice versus a strain 
with reduced EB sensitivity. They reported not to have uncovered any fitness costs 
related to reduced EB sensitivity. It is possible that resistance may incur fitness costs 
linked to environmental parameters. For example, do resistant lice show lower tolerance 
to more extreme salinities versus naïve lice? 
 
This study has demonstrated that where consistency of response over time is required, the 
naïve and resistant lice held at MERL are available as predictable reference strains. Their 
stability over time supports the idea that they are valid reference points for evaluation of 
the efficacy of potential new chemotherapeutants and feed additives, new combination 
treatments, and to investigate cross-resistance towards different pharmaceutical products. 
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